Table 3.

Global and Latin American rates of awareness, treatment and control of cardiovascular diseases – PURE study

Variables	Global prevalence (%)	Latin American prevalence (%)
Hypertension
Awareness	46.5	57.1
Treatment	40.6	52.8
Control	13.2	18.8
Secondary preventive drugs
Antiplatelet drugs	25.3	29.0
β-blockers	17.4	28.8
ACE / ARB	19.5	37.9
Statins	14.6	15.0
Healthy lifestyle
Smoking cessation	53.4	67.2
Physical activity	35.1	41.5*
Healthy diets	39.0	43.2*

Extracted values from published data [32-34]. *Data for the global lower-middle-income countries, where the Latin Americans are included. ACE: angiotensin-converting-enzyme inhibitors. ARB: angiotensin-receptor blockers.